Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
Journal
Journal of hepatology
Date Issued
2024
Author(s)
Younossi, Zobair M
Alqahtani, Saleh A
Alswat, Khalid
Yilmaz, Yusuf
Keklikkiran, Caglayan
Funuyet-Salas, Jesús
Romero-Gómez, Manuel
Fan, Jian-Gao
Zheng, Ming-Hua
El-Kassas, Mohamed
Castera, Laurent
Wai-Sun Wong, Vincent
Zelber-Sagi, Shira
Allen, Alina M
Lam, Brian
Treeprasertsuk, Sombat
Hameed, Saeed
Takahashi, Hirokazu
Kawaguchi, Takumi
Schattenberg, Jörn M
Duseja, Ajay
Newsome, Phil N
Francque, Sven
Spearman, C Wendy
Castellanos Fernández, Marlen I
Burra, Patrizia
Roberts, Stuart K
Chan, Wah-Kheong
Arrese, Marco
Silva, Marcelo
Rinella, Mary
Singal, Ashwani K
Gordon, Stuart
Fuchs, Michael
Alkhouri, Naim
Cusi, Kenneth
Loomba, Rohit
Ranagan, Jane
Eskridge, Wayne
Kautz, Achim
Ong, Janus P
Kugelmas, Marcelo
Eguchi, Yuichiro
Diago, Moises
Yu, Ming-Lung
Gerber, Lynn
Fornaresio, Lisa
Nader, Fatema
Henry, Linda
Racila, Andrei
Golabi, Pegah
Stepanova, Maria
Carrieri, Patrizia
Lazarus, Jeffrey V
Abstract
Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this cross-sectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) and healthcare providers.
Subjects
MASH; MASLD; SLD; communication; discrimination; fatty liver; metabolic; patient-reported outcomes
SDGs
Type
journal article